CV Sciences, Inc.

CVSI · OTC · SIC 2834: Pharmaceutical Preparations
247
SEC Filings

Business Summary

PART I Overview CV Sciences, Inc. (CV Sciences, the Company, we, our or us) is a consumer wellness company specializing in nutraceuticals and plant-based foods. Our hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Our +PlusCBD branded products are sold at select retail locations throughout the U.S. and are the top-selling brands of hemp extracts in the natural...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCVSIdiscussed_in_filing Cybersecurity
topic_mentionCVSIdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126598EDGAR38K words
2025-03-272024-12-310000950170-25-046180EDGAR—
2024-03-292023-12-310000950170-24-038736EDGAR—
2023-03-302022-12-310001510964-23-000016EDGAR—
2022-04-042021-12-310001510964-22-000033EDGAR—
2021-03-192020-12-310001510964-21-000012EDGAR—
2020-03-302019-12-310001510964-20-000026EDGAR—
2019-03-122018-12-310001510964-19-000007EDGAR—
2018-03-302017-12-310001683168-18-000816EDGAR—
2017-03-312016-12-310001683168-17-000725EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280515EDGAR25K words
2025-08-132025-06-300000950170-25-108171EDGAR—
2025-05-142025-03-310000950170-25-071559EDGAR—
2024-11-142024-09-300000950170-24-127040EDGAR—
2024-08-132024-06-300000950170-24-096390EDGAR—
2024-05-152024-03-310000950170-24-059926EDGAR—
2023-11-142023-09-300001510964-23-000039EDGAR—
2023-08-142023-06-300001510964-23-000032EDGAR—
2023-05-152023-03-310001510964-23-000024EDGAR—
2022-11-142022-09-300001510964-22-000088EDGAR—
2022-08-152022-06-300001510964-22-000069EDGAR—
2022-05-162022-03-310001510964-22-000043EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126211EDGAR5K words
2026-03-100001193125-26-100436EDGAR—
2025-11-130001193125-25-280116EDGAR—
2025-10-100001193125-25-237188EDGAR—
2025-09-180001193125-25-207436EDGAR—
2025-08-130000950170-25-107984EDGAR—
2025-06-050000950170-25-081934EDGAR—
2025-05-140000950170-25-071347EDGAR—
2025-03-270000950170-25-045761EDGAR—
2025-02-200000950170-25-023618EDGAR—

247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001510964
TickerCVSI
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6e4d1c89aa10500d49769064547efea37ef24f6ce93f5fc7a30eae7b51a8ef77
parent: 3c041c3c91d3097a204bff9a36df1caf57309d4c2379c5b2a684b0254e3ce9e8
content hash: bd6b4fb7bd81340b37a963ea89f136bbd6f103c45a2b55fc1b81007e405a9710
signed: 2026-04-13T04:44:34.479Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf